(Q35652920)

English

Prognostic significance of plasma osteopontin in patients with locoregionally advanced head and neck squamous cell carcinoma treated on TROG 02.02 phase III trial

scientific article published on 17 November 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 August 2017

Prognostic significance of plasma osteopontin in patients with locoregionally advanced head and neck squamous cell carcinoma treated on TROG 02.02 phase III trial (English)

1 reference

Europe PubMed Central

9 August 2017

phase III clinical trial

0 references

head and neck squamous cell carcinoma

1 reference

based on heuristic

inferred from title

object named as

Grant A McArthur

7

0 references

Lester J. Peters

10

object named as

Lester Peters

1 reference

Europe PubMed Central

9 August 2017

1

object named as

Annette M Lim

1 reference

Europe PubMed Central

9 August 2017

2

object named as

Danny Rischin

1 reference

Europe PubMed Central

9 August 2017

author name string

Richard Fisher

3

1 reference

Europe PubMed Central

9 August 2017

Hongbin Cao

4

1 reference

Europe PubMed Central

9 August 2017

Kathleen Kwok

5

1 reference

Europe PubMed Central

9 August 2017

Daniel Truong

6

1 reference

Europe PubMed Central

9 August 2017

Richard J Young

8

1 reference

Europe PubMed Central

9 August 2017

Amato Giaccia

9

1 reference

Europe PubMed Central

9 August 2017

Quynh-Thu Le

11

1 reference

Europe PubMed Central

9 August 2017

language of work or name

0 references

publication date

17 November 2011

1 reference

Europe PubMed Central

9 August 2017

Clinical Cancer Research

1 reference

Europe PubMed Central

9 August 2017

18

1 reference

Europe PubMed Central

9 August 2017

1

1 reference

Europe PubMed Central

9 August 2017

301-307

1 reference

Europe PubMed Central

9 August 2017

High stromal carbonic anhydrase IX expression is associated with decreased survival in P16-negative head-and-neck tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251655

12 July 2018

Osteopontin is a marker for cancer aggressiveness and patient survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251655

12 July 2018

Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251655

12 July 2018

Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a phase III trial of the Trans-Tasman Radiation Oncology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251655

12 July 2018

Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251655

12 July 2018

Matricellular proteins: from homeostasis to inflammation, cancer, and metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251655

12 July 2018

The role of osteopontin in the development of albuminuria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251655

12 July 2018

Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251655

12 July 2018

Development of fragment-specific osteopontin antibodies and ELISA for quantification in human metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251655

12 July 2018

Up-regulation of SIBLING proteins and correlation with cognate MMP expression in oral cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251655

12 July 2018

Plasma osteopontin levels in patients with head and neck cancer and cervix cancer are critically dependent on the choice of ELISA system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251655

12 July 2018

Transcriptional regulation of osteopontin and the metastatic phenotype: evidence for a Ras-activated enhancer in the human OPN promoter

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251655

12 July 2018

Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251655

12 July 2018

Factor H binding to bone sialoprotein and osteopontin enables tumor cell evasion of complement-mediated attack

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251655

12 July 2018

A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251655

12 July 2018

Osteopontin and the bone remodeling sequence. Colloidal-gold immunocytochemistry of an interfacial extracellular matrix protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251655

12 July 2018

HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251655

25 September 2018

Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation O

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251655

25 September 2018

Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251655

25 September 2018

Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251655

25 September 2018

Small integrin binding ligand N-linked glycoprotein gene family expression in different cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251655

25 September 2018

Three small integrin binding ligand N-linked glycoproteins (SIBLINGs) bind and activate specific matrix metalloproteinases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251655

25 September 2018

Plasma osteopontin levels are associated with the presence and extent of coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22096023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteopontin as a novel prognostic marker in stable ischaemic heart disease: a 3-year follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22096023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modification of Hypoxia-Induced Radioresistance in Tumors by the Use of Oxygen and Sensitizers

1 reference

https://pubmed.ncbi.nlm.nih.gov/22096023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1158/1078-0432.CCR-11-2295

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35652920&oldid=2109540745"